JLE

Epileptic Disorders

MENU

Personalized treatment with retigabine for pharmacoresistant epilepsy arising from a pathogenic variant in the KCNQ2 selectivity filter Volume 23, issue 5, October 2021

Export citation

Citation of this article, in the « Vancouver » format:

Andreea Nissenkorn, Polina Kornilov, Asher Peretz, Lubov Blumkin, Gali Heimer, Bruria Ben-Zeev, Bernard Attali. Personalized treatment with retigabine for pharmacoresistant epilepsy arising from a pathogenic variant in the KCNQ2 selectivity filter. Epileptic Disorders. 2021;23(5):695-705. doi:10.1684/epd.2021.1315

Download (RIS) Add to my bibliography

The citations in my bibliography.